Help researchers by participating in a clinical trial of an experimental potential nasal spray vaccine for COVID-19.

At present, all approved vaccines for COVID-19 are administered by injection into the upper arm. The trial vaccine is administered into the nasal passage, similar to an allergy spray.

We are looking for people who:

• are aged between 18 and 55 years inclusive
• are in good general health
• have NOT received a COVID-19 vaccine or have NOT been infected with SARS-CoV-2 in the last 4 months
• have a Body mass index (BMI) between 18.0 to 32.0 kg/m2, inclusive
• can attend up to 8 visits for a period of up to 6 months at our Sippy Downs clinic on the Sunshine Coast

Eligible participants will be reimbursed for their time on the trial.

Full title: A Randomized, Double-Blind, Placebo- and OMV-Controlled Phase I Study to Evaluate the Safety, Tolerance, and Immunogenicity of the Avacc 10 Vaccine Administered Intranasally to Healthy Adult Volunteers

HREC approval: Alfred Hospital Ethics Committee

Privacy notice: Personal information collected by USC Clinical Trials is handled in accordance with the Information Privacy Act 2009. USC Clinical Trials is collecting your contact information as provided in the above form to contact you about this and future clinical trials, and for quality and feedback purposes. All personal information will be securely stored and only accessible by authorised persons. Your personal information will not be disclosed to other third parties without consent, unless required by law. For information about how USC protects your personal information, or to learn about your right to access your own personal information, please see our website at www.usc.edu.au/privacy.